Campbell Wealth Management Amgen Inc Transaction History

Campbell Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $1,051 - $1,277	4 Added 0.49%	822 $257,000
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $219,935 - $265,490	818 New	818 $233,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $178,199 - $221,239	815 New	815 $219,000
Q3 2020 Nov 02, 2020	SELL	$234.65 - $260.95 $50,919 - $56,626	-217 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$197.81 - $242.74 $42,924 - $52,674	217 New	217 $51,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Campbell Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Campbell Wealth Management with notifications on news.